secwatch / observer
8-K filed May 1, 2023, 7:59 PM ET ticker SGRY CIK 0001638833
earnings confidence high sentiment neutral materiality 0.75

Surgery Partners Q1 revenue up 11.7% to $666.2M, net loss $24.9M, raises 2023 EBITDA guidance >$430M

Surgery Partners, Inc.

2023-Q1 EPS reported -$0.20 revenue$666,200,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Surgery Partners, Inc. updated its full year 2023 guidance (raised).

Period
full year 2023
Guidance
raised
Result
guidance update
Exact text from the filing
The Company raises projected 2023 Adjusted EBITDA to be greater than $430 million.
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Surgery Partners, Inc. reported first quarter ended March 31, 2023 results: revenue $666.2 million, net income $(24.9) million. Guidance raised.

Period
first quarter ended March 31, 2023
Revenue
$666.2 million
Net income
$(24.9) million
Guidance
raised
Result
reported results
Exact text from the filing
a leading provider of surgical services, today announced financial results for the first quarter ended March 31, 2023. • Revenue increased 11.7% from the prior year period to $666.2 million ◦ Same-facility revenue increasing 10.3% • Net loss attributable to Surgery Partners, Inc. was $24.9 million ◦ Adjusted EBITDA of $90.1 million; 17% greater than the prior year
View on SEC.gov

Browse all earnings releases →

Surgery Partners, Inc. filing history →

Source: SEC EDGAR
accession 0001638833-23-000067
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.